BY VANESSA ALEXANDRA KJAER
-
Pharma companies bracing for tougher price negotiations in Europe
The Trump management’s press to reduced medication rates is influencing markets worldwide.
-
Eli Lilly calls attention to product advantages ahead of US tablet launch
Novo Nordisk’s Wegovy tablet computer is currently commonly readily available in the United States, while Eli Lilly’s completing medication is being prepared with a con…
-
Johnson & Johnson signs US deal on lower drug prices in exchange for tariff exemptions
The arrangement consists of rate decreases, involvement in TrumpRx, and brand-new manufacturing facilities in the United States.
-
Former Demant director appointed to new board position at Natus Sensory
Arne Boye Nielsen brings his several years of experience, acquired throughout a stormy occupation at Demant, to the board of Natus Sensory.
-
Former Demant director appointed to new board position at Natus Sensory
Arne Boye Nielsen brings his many years of experience, gained during a turbulent career at Demant, to the board of Natus Sensory.
-
Orifarm recruits new head of business development from Hamburg
Orifarm’s brand-new elderly administration ash, Jutta Schnirring-Mayer, will certainly speed up the development of Orifarm’s generics service in Europe.
-
Danish partner in new drug purchaser in the US: “The US market for drugs has broken down”
A brand-new start-up with its origins in the Danish participating spirit intends to reinvent the United States medical care market by ending up being a brand-new kind of intermedia…
-
Investors have sky-high expectations for Eli Lilly
Novo Nordisk experiences a decline in its share price, while Eli Lilly is priced significantly higher due to its success in the weight-loss market.
-
Carles Reina launches €12.9 million solo GP fund Baobab Ventures to back early-stage AI and robotics startups
Carles Reina, the angel investor on the lend a hand of Revolut and ElevenLabs, has unveiled a €12.9 million ($15 million) solo GP fund primarily based entirely entirely in London, Baobab Ventures , to lend a hand pre-Seed and Seed stage founders across AI, robotics, and defense. The new fund, which used to be oversubscribed
-
Coloplast gains foothold in Costa Rica
This is partially in feedback to Coloplast changing its emphasis from China to the United States.
